These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2852438)

  • 1. Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum.
    Westlind-Danielsson A; Andell S; Abens J; Bartfai T
    Acta Physiol Scand; 1988 Mar; 132(3):425-30. PubMed ID: 2852438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J; Li W; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.
    Olianas MC; Onali P; Neff NH; Costa E
    Mol Pharmacol; 1983 Mar; 23(2):393-8. PubMed ID: 6188035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
    Walker MW; Miller RJ
    Mol Pharmacol; 1988 Dec; 34(6):779-92. PubMed ID: 2849045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus.
    Petrenko S; Olianas MC; Onali P; Gessa GL
    Eur J Pharmacol; 1987 Apr; 136(3):425-8. PubMed ID: 3609127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
    Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
    J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striatum.
    Mickevicius CK; Harrison JK; Gnegy ME
    Mol Pharmacol; 1986 Nov; 30(5):469-75. PubMed ID: 3773884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of 125I-neuropeptide Y with rat cardiac membranes.
    Sheriff S; Rigel DF; Fischer JE; Balasubramaniam A
    Neuropeptides; 1990 Mar; 15(3):157-60. PubMed ID: 2174520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis.
    Voisin T; Rouyer-Fessard C; Laburthe M
    Am J Physiol; 1990 May; 258(5 Pt 1):G753-9. PubMed ID: 2159240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of peptide YY receptors in the brain.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Shii K; Yokono K; Mizuno N; Baba S
    Endocrinology; 1989 Jan; 124(1):402-9. PubMed ID: 2535812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y as a partial agonist of the Y1 receptor.
    Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
    Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system.
    Battaglia G; Webster EL; De Souza EB
    Synapse; 1987; 1(6):572-81. PubMed ID: 2843998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the binding of [3H]proprionyl-neuropeptide Y to rat and human frontal cortical membranes.
    Widdowson PS; Halaris AE
    J Neurochem; 1990 Sep; 55(3):956-62. PubMed ID: 2384761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
    Odagaki Y; Nishi N; Nakagawa S; Koyama T
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1250-6. PubMed ID: 10565849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes.
    Balasubramaniam A; Sheriff S; Rigel DF; Fischer JE
    Peptides; 1990; 11(3):545-50. PubMed ID: 2166278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.